Sumatriptan and Vortioxetine share 9 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.346 means 35% of the combined target set is bound by both compounds. The IDF-weighted score of 0.333 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Sumatriptan and Vortioxetine have in common?
Sumatriptan and Vortioxetine share 9 molecular targets with a Jaccard similarity of 35%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Sumatriptan and Vortioxetine be combined?
Sumatriptan and Vortioxetine share 9 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Sumatriptan or Vortioxetine?
In the BiohacksAI corpus: Sumatriptan has 298 PubMed-indexed studies, Vortioxetine has 294 studies.